Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Jeffrey M. Dayno is recorded as CEO and Board Member at Harmony Biosciences Holdings, Inc. (HRMY). Harmony Biosciences Holdings, Inc. reported in an 8-K filed April 24, 2023 that Jeffrey M. Dayno was appointed Class I Director, effective April 24, 2023. Harmony Biosciences Holdings, Inc. reported in an 8-K filed April 24, 2023 that Jeffrey M. Dayno was appointed President and Chief Executive Officer, effective April 24, 2023. Harmony Biosciences Holdings, Inc. reported in an 8-K filed January 6, 2023 that Jeffrey M. Dayno was appointed Interim Chief Executive Officer, effective January 6, 2023. Jeffrey M. Dayno has spoken on 2 earnings calls and 1 other investor event across 1 company, most recently for Harmony Biosciences Holdings, Inc. on August 4, 2026.
“In connection with his appointment, Dr. Dayno has also been appointed to the Board as a Class I Director, filling the previously announced vacancy on the Board created by the departure of John C. Jacobs, to serve until the Company's 2024 Annual Meeting of Stockholders and until his successor is duly elected and qualified or until his earlier death, resignation, retirement, disqualification or removal.”
“Dr. Jeffrey M. Dayno, the Company's current Interim President and Chief Executive Officer and Chief Medical Officer, has been appointed by the Board of Directors of the Company (the "Board") as President and Chief Executive Officer ("CEO") of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2023-04-24–present
2023-04-24–present
Recorded roles and call appearances connecting this person to public companies.
CEO, Board Member
2023-04-24–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
